News
First Stool DNA Colorectal Cancer Screening Test OK’d by FDA
Exact Sciences has announced the Food and Drug Administration (FDA) approval of Cologuard, the first non-invasive DNA screening test for colorectal cancer.
Your search for colorectal cancer returned 1910 results
Slideshow
Colorectal Cancer
Colorectal cancer is the 3rd most common cancer, and the 2nd most common cause of death in the United States. In 2012, there will be 103,170 new cases of colon cancer and 40,290 new cases of rectal cancer diagnosed. As a result, there will be over 51,000 deaths from colorectal cancer this year; most of…
Drug News
Statins After Colon Cancer Diagnosis May Lower Mortality Risk
For patients with newly diagnosed colorectal cancer, statin use is associated with reduced cancer-specific mortality risk.
Drug News
Postdiagnosis Calcium Intake Inversely Linked to Death in CRC
For patients with colorectal cancer, postdiagnosis total calcium intake may be inversely associated with the risk of death.
Drug News
Breath Test Shows Potential for Detecting Colorectal Cancer
Analysis of volatile organic compounds (VOCs) from breath samples is able to distinguish healthy patients from those with colorectal cancer with more than 75% accuracy.
Drug News
DDW: Flexible Sigmoidoscopy Tied to Lower CRC Incidence
Screening with flexible sigmoidoscopy correlates with significant reductions in the incidence of distal and proximal colorectal cancer and in distal colorectal cancer mortality.
News
Genetics Could Play Role With Aspirin, NSAIDs, and CRC Risk
Researchers from Indiana University have identified genetic markers to hep determine which patients benefit from regular aspirin and other NSAIDs for reducing the risk of developing colorectal cancer.
News
Drinking More Coffee May Lower Risk of Colorectal Cancer, Study Finds
Coffee consumption may lower the risk of colorectal cancer, according to findings from a new study published in Cancer Epidemiology, Biomarkers & Prevention.
Drug News
Colorectal Cancer Incidence Down With Higher Screening Rates
As rates of screening have increased, there has been a significant decline in the incidence of colorectal cancer in the United States.
Drug News
Colorectal Cancer Screening Provides Lasting Benefits
Lower endoscopy and fecal occult-blood testing screening correlate with lasting reductions in colorectal cancer mortality.
